Campus alert status is yellow: For the latest campus alert status, news and resources, visit

Search Close Search
Search Close Search
Page Menu

Diet, Microbiome, and IBD during pregnancy

The early microbiome dictates the development of the nascent immune system, with potential long-term consequences on health outcomes. Infants born to mothers with IBD are at a significantly increased risk of developing the disease. Those infants also harbor a pro-inflammatory microbiome that induces aberrant development of the immune system. Therefore, modulation of the microbiome in early life could be an efficient and effective approach to promote a healthier immune system and potentially reduce IBD risk. Thus, we are:

  • Investigating whether our pregnancy-adapted IBD-AID™ intervention during pregnancy could beneficially shift the microbiome of IBD mothers and their babies, thereby promoting a healthier immune system during a critical time of its development.
  • Creating neonatal probiotics to protect infants from IBD. We posit that by using probiotics to selectively restore the beneficial newborn microbiome, infants will develop a healthy, non-inflamed gut thus reducing the risk of IBD.

 We are currently recruiting expectant mothers with IBD ($900 compensation for participation in the trial). Interested? please visit: